Evolving treatment landscape of advanced endometrial cancer - A current perspective from a German tertiary referral center for gynecological oncology

被引:0
|
作者
Ralser, Damian J. [1 ,2 ]
Condic, Mateja [1 ]
Otten, Lucia A. [1 ]
Koensgen, Dominique [1 ]
Stope, Matthias B. [1 ]
Egger, Eva K. [1 ]
Mustea, Alexander [1 ]
机构
[1] Univ Hosp Bonn, Dept Gynecol & Gynecol Oncol, Bonn, Germany
[2] Univ Hosp Bonn, Dept Gynecol & Gynecol Oncol, Venusberg Campus 1, D-53127 Bonn, Germany
关键词
Endometrial cancer; Immunotherapy;
D O I
10.1016/j.ejogrb.2023.01.008
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
[No abstract available]
引用
收藏
页码:61 / 63
页数:3
相关论文
共 47 条
  • [41] Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry
    Hartkopf, Andreas D.
    Huober, Jens
    Volz, Bernhard
    Nabieva, Naiba
    Taran, Florin-Andrei
    Schwitulla, Judith
    Overkamp, Friedrich
    Kolberg, Hans-Christian
    Hadji, Peyman
    Tesch, Hans
    Haeberle, Lothar
    Ettl, Johannes
    Lux, Michael P.
    Lueftner, Diana
    Wallwiener, Markus
    Mueller, Volkmar
    Beckmann, Matthias W.
    Belleville, Erik
    Wimberger, Pauline
    Hielscher, Carsten
    Geberth, Matthias
    Fersis, Nikos
    Abenhardt, Wolfgang
    Kurbacher, Christian
    Wuerstlein, Rachel
    Thomssen, Christoph
    Untch, Michael
    Fasching, Peter A.
    Janni, Wolfgang
    Fehm, Tanja N.
    Wallwiener, Diethelm
    Brucker, Sara Y.
    Schneeweiss, Andreas
    BREAST, 2018, 37 : 42 - 51
  • [42] Current status of and barriers to the treatment of advanced-stage liver cancer in China: a questionnaire-based study from the perspective of doctors
    Wei, Qiaoxin
    Zhou, Haiyang
    Hou, Xinhui
    Liu, Xiaoping
    Chen, Sisi
    Huang, Xueying
    Chen, Yu
    Liu, Mei
    Duan, Zhongping
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [43] Current status of and barriers to the treatment of advanced-stage liver cancer in China: a questionnaire-based study from the perspective of doctors
    Qiaoxin Wei
    Haiyang Zhou
    Xinhui Hou
    Xiaoping Liu
    Sisi Chen
    Xueying Huang
    Yu Chen
    Mei Liu
    Zhongping Duan
    BMC Gastroenterology, 22
  • [44] Treatment of Advanced or Recurrent Endometrial Carcinoma With Doxorubicin in Patients Progressing After Paclitaxel/Carboplatin Memorial Sloan-Kettering Cancer Center Experience From 1995 to 2009
    Makker, Vicky
    Hensley, Martee L.
    Zhou, Qin
    Iasonos, Alexia
    Aghajanian, Carol. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (05) : 929 - 934
  • [45] Genomic testing and treatment landscape in patients with advanced non-small cell lung cancer (aNSCLC) using real-world data from community oncology practices.
    Gierman, Hinco Jasper
    Goldfarb, Seth
    Labrador, Monica
    Weipert, Caroline M.
    Getty, Bill
    Skrzypczak, Stan M.
    Catasus, Casey
    Carbral, Steve
    Singaraju, Mallika
    Singleton, Nick
    Pai, Nikhil
    Sanchez, Jose
    Webster, Jennifer
    Raymond, Victoria M.
    Lanman, Richard B.
    Malik, Ash
    Scott, Jeffrey A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [46] Treatment with (chemo)-radiation in old patients (≥76 years of age) with newly diagnosed non-metastatic squamous cell cancer of the head and neck region: real-world data from a tertiary referral center
    Winkler, Leah-Sophie
    Haderlein, Marlen
    Semrau, Sabine
    Putz, Florian
    Hoefler, Daniel
    Mueller, Sarina K.
    Iro, Heinrich
    Kesting, Marco
    Fietkau, Rainer
    Schubert, Philipp
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [47] Five-year Survival Outcome of patients with synchronous oligometastatic or locally advanced Non-small cell lung cancer after definitive primary treatment: Results from the West German Cancer Center, a prospective registry trial
    Guberina, Maja
    Poettgen, Christoph
    Guberina, Nika
    Wiesweg, Marcel
    Metzenmacher, Martin
    Richlitzki, Cedric
    Hoffmann, Christian
    Eberhardt, Wilfried
    Forsting, Michael
    Herrmann, Ken
    Theegarten, Dirk
    Boeluekbas, Servet
    Aigner, Clemens
    Darwiche, Kaid
    Stuschke, Martin
    Schuler, Martin
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 128 - 128